News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|December 15, 2023

Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

Episodes in this series

EP. 1 Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

EP. 1 Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

Video 1 - 3 KOLs are featured in, "Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression"

EP. 2 Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression

Video 2 - 3 KOLs are featured in, "Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis"

EP. 3 Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis

3 KOLs in this program

EP. 4 Examining Key Unmet Needs in Multiple Sclerosis

3 KOLs in this program

EP. 5 Patient Satisfaction: Opportunity for Better Multiple Sclerosis Therapies

A panel of 3 experts on multiple sclerosis

EP. 6 MS Treatment Guidelines: Expert Insights on Updates and Decision-Making

A panel of 3 experts on multiple sclerosis

EP. 7 Incorporating a Subcutaneous Novel Therapy into Multiple Sclerosis Treatment

A panel of 3 experts on multiple sclerosis

EP. 8 Examining Challenges with Drug Switching and Step Therapy in MS Treatment

A panel of 3 experts on multiple sclerosis

EP. 9 Typical Payer Coverage Criteria for Multiple Sclerosis Therapies

A panel of 3 experts on multiple sclerosis

EP. 10 BTK Inhibitors' Rationale and Potential Role in Multiple Sclerosis Treatment

A panel of 3 experts on multiple sclerosis

EP. 11 Updates in Recent Clinical Trials in the Treatment of Multiple Sclerosis

A panel of 3 experts on multiple sclerosis

EP. 12 Primary Progressive Multiple Sclerosis Treatment Landscape: Emerging Therapies

A panel of 3 experts on multiple sclerosis

EP. 13 Multiple Sclerosis: Looking Toward the Future

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

4 Experts are featured in this series

Switching Therapies, Managing Adverse Effects, and Adherence Challenges

ByGus Alva, MD, DFAPA,Rishi Kakar, MD,Philip Harvey, MD,Gerald Maguire, MD

December 29th 2025

4 Experts are featured in this series

First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing

ByGus Alva, MD, DFAPA,Rishi Kakar, MD,Philip Harvey, MD,Gerald Maguire, MD

December 29th 2025

4 experts are featured in this series.

Linvoseltamab for Relapsed/Refractory Multiple Myeloma

ByRyan Haumschild, PharmD, MS, MBA,Shahrier Hossain, PharmD,Michael Singel, PharmD,Naresh Bumma, MD

December 29th 2025

4 experts are featured in this series.

CAR-T Scheduling and the Role of Combination Therapy

ByRyan Haumschild, PharmD, MS, MBA,Shahrier Hossain, PharmD,Michael Singel, PharmD,Naresh Bumma, MD

December 29th 2025

Unmet Needs and the Future of Desmoid Tumor Management

ByScott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA ,Mrinal Gounder, MD,Gina D'Amato, MD,Ryan Haumschild, PharmD, MS, MBA,Richard Riedel, MD,Alexander Lazar, M.D., Ph.D

December 23rd 2025

Trending on AJMC

Meta-Analysis Supports RSV Vaccine Efficacy and Safety in Older Adults

Top 5 Most-Read Cardiovascular Content of 2025

Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health

Top 5 Most-Read HIV Articles of 2025

Top 5 Most-Read SAP Content in 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.